FDA Approved: CYCLOSPORINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for cyclosporine (Apotex Corp.) under an ANDA, indicating approval of a supplemental update to this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant Rejection
• Plaque Psoriasis
• Rheumatoid Arthritis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

SUPPL AP for CYCLOSPORINE (CYCLOSPORINE)